Structure based prediction of selective MraY inhibitors.

Area of Science:

• Biochemistry
• Pharmacology
• Computational Chemistry

Background:

• Antibiotic resistance poses a significant public health threat, necessitating novel therapeutic strategies.
• Targeting bacterial cell wall synthesis is a proven antibiotic approach.
• MraY (Phospho-N-acetylmuramoyl-pentapeptide translocase) is a key enzyme in bacterial cell wall synthesis and a potential antibiotic target.
• Existing inhibitors like tunicamycin lack selectivity, cross-reacting with human GPT (GlcNAc-1-P-transferase).

Purpose of the Study:

• To identify selective inhibitors of the bacterial MraY enzyme.
• To develop new antibiotic candidates with improved MraY selectivity, minimizing off-target effects on human enzymes.

Main Methods:

• Virtual screening of 45,411 compounds against MraY.
• Molecular dynamics simulations to assess binding stability and selectivity.
• Comparative structural interaction analysis between MraY and hGPT.

Main Results:

• Identification of potential selective MraY inhibitors through computational screening.
• Evaluation of binding interactions and stability for MraY and hGPT.
• Shortlisting of three compounds exhibiting promising selectivity for MraY over hGPT.

Conclusions:

• The study successfully identified potential selective MraY inhibitors using computational methods.
• These compounds represent promising leads for developing new antibiotics against resistant bacteria.
• Further experimental validation is warranted to confirm the efficacy and safety of these inhibitors.